PMDA — authorised 28 September 2015
- Marketing authorisation holder: Taisho Pharmaceutical Co., Ltd.
- Status: approved
PMDA authorised Loqoa on 28 September 2015
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Yes. PMDA authorised it on 28 September 2015; PMDA has authorised it.
Taisho Pharmaceutical Co., Ltd. holds the Japanese marketing authorisation.